Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart

Hessel Honkoop, Dennis E.M. de Bakker, Alla Aharonov, Fabian Kruse, Avraham Shakked, Phong D. Nguyen, Cecilia de Heus, Laurence Garric, Mauro J Muraro, Adam Shoffner, Federico Tessadori, Joshua C. Peterson, Wendy Noort, Alberto Bertozzi, Gilbert Weidinger, George Posthuma, Dominic Grün, Willem J. van der Laarse, Judith Klumperman, Richard T. JaspersKenneth D. Poss, Alexander van Oudenaarden, Eldad Tzahor, Jeroen Bakkers*

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

While the heart regenerates poorly in mammals, efficient heart regeneration occurs in zebrafish. Studies in zebrafish have resulted in a model in which preexisting cardiomyocytes dedifferentiate and reinitiate proliferation to replace the lost myocardium. To identify which processes occur in proliferating cardiomyocytes we have used a single-cell RNA-sequencing approach. We uncovered that proliferating border zone cardiomyocytes have very distinct transcriptomes compared to the nonproliferating remote cardiomyocytes and that they resemble embryonic cardiomyocytes. Moreover, these cells have reduced expression of mitochondrial genes and reduced mitochondrial activity, while glycolysis gene expression and glucose uptake are increased, indicative for metabolic reprogramming. Furthermore, we find that the metabolic reprogramming of border zone cardiomyocytes is induced by Nrg1/ErbB2 signaling and is important for their proliferation. This mechanism is conserved in murine hearts in which cardiomyocyte proliferation is induced by activating ErbB2 signaling. Together these results demonstrate that glycolysis regulates cardiomyocyte proliferation during heart regeneration.

Original languageEnglish
Article numbere50163
JournaleLife
Volume8
DOIs
Publication statusPublished - 1 Dec 2019

Funding

Funding: J.B. acknowledges support from the Netherlands Cardiovascular Research Initiative and the Dutch Heart Foundation (grants CVON2011-12 HUSTCARE and Cobra3) and ERA-CVD grant CARDIO-PRO JCT2016-40-080. L.G. was supported by an EMBO long-term fellowship. P.D.N. is supported by an EMBO Long Term Fellowship ALTF1129- (016.186.017-3). G.W. was funded by the Deutsche Forschungsgemeinschaft (SFB 1149, 01KL1704). K.D.P. acknowledges support from the American Heart Association, Foundation

FundersFunder number
Dutch Heart FoundationCobra3, CVON2011-12 HUSTCARE
EMBO Long TermALTF1129-2015, LT001404/2017-L
EU ERA-CVD01KL1704
Foundation
Foundation Leducq
G.W.
NWO-ZonMw Veni016.186.017-3
Netherlands Cardiovascular Research
Netherlands CardioVascular Research Initiative
National Institutes of HealthR01 HL136182, R01 HL081674, R01 HL131319
National Cancer InstituteR15CA186017
American Heart Association
Deutsche ForschungsgemeinschaftSFB 1149
Bundesministerium für Bildung und Forschung
EMBO

    Fingerprint

    Dive into the research topics of 'Single-cell analysis uncovers that metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart'. Together they form a unique fingerprint.

    Cite this